日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparison of RNA- and DNA-based 16S amplicon sequencing to find the optimal approach for the analysis of the uterine microbiome.

比较基于 RNA 和 DNA 的 16S 扩增子测序，以找到分析子宫微生物组的最佳方法

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-00969-5
Dyroff Antonia I, López-Valiñas Álvaro, Magalhaes Humberto B, Podico Giorgia, Canisso Igor F, Almiñana Carmen, Bauersachs Stefan
微生物学
发表日期：2025
文献求助 收藏

Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study

布鲁顿酪氨酸激酶抑制剂evobrutinib治疗复发型多发性硬化症3.5年以上的疗效和安全性结果：一项包含脑脊液亚研究的II期随机临床试验的长期随访

期刊:Multiple Sclerosis Journal
影响因子:5
doi:10.1177/13524585241234783
Montalban, Xavier; Piasecka-Stryczynska, Karolina; Kuhle, Jens; Benkert, Pascal; Arnold, Douglas L; Weber, Martin S; Seitzinger, Andrea; Guehring, Hans; Shaw, Jamie; Tomic, Davorka; Hyvert, Yann; Harlow, Danielle E; Dyroff, Martin; Wolinsky, Jerry S
神经科学
信号转导
多发性硬化症
发表日期：2024
文献求助 收藏

Determination of a clinically effective evobrutinib dose: Exposure-response analyses of a phase II relapsing multiple sclerosis study

确定临床有效剂量的evobrutinib：一项II期复发型多发性硬化症研究的暴露-反应分析

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13407
Papasouliotis, Orestis; Mitchell, David; Girard, Pascal; Dangond, Fernando; Dyroff, Martin
神经科学
多发性硬化症
发表日期：2022
文献求助 收藏

Population pharmacokinetic and pharmacodynamic modeling of evobrutinib in healthy adult participants

在健康成年受试者中对依沃替尼进行群体药代动力学和药效学建模

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13417
Papasouliotis, Orestis; Mitchell, David; Girard, Pascal; Dyroff, Martin
发表日期：2022
文献求助 收藏

A rapid high-precision analytical method for triple oxygen isotope analysis of CO(2) gas using tunable infrared laser direct absorption spectroscopy

利用可调谐红外激光直接吸收光谱法对CO₂气体进行三重氧同位素分析的快速高精度分析方法

期刊:Rapid Communications in Mass Spectrometry
影响因子:1.7
doi:10.1002/rcm.9391
Perdue, Nathan; Sharp, Zachary; Nelson, David; Wehr, Rick; Dyroff, Christoph
发表日期：2022
文献求助 收藏

Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants

Evobrutinib，一种共价布鲁顿酪氨酸激酶抑制剂：健康受试者体内的质量平衡、消除途径和代谢

期刊:Cts-Clinical and Translational Science
影响因子:2.8
doi:10.1111/cts.13108
Scheible, Holger; Dyroff, Martin; Seithel-Keuth, Annick; Harrison-Moench, Eleanor; Mammasse, Nadra; Port, Andreas; Bachmann, Angelika; Dong, Jennifer; van Lier, Jan Jaap; Tracewell, William; Mitchell, David
信号转导
代谢
发表日期：2021
文献求助 收藏

A global database of water vapor isotopes measured with high temporal resolution infrared laser spectroscopy

利用高时间分辨率红外激光光谱法测量的全球水蒸气同位素数据库

期刊:Scientific Data
影响因子:6.9
doi:10.1038/sdata.2018.302
Wei, Zhongwang; Lee, Xuhui; Aemisegger, Franziska; Benetti, Marion; Berkelhammer, Max; Casado, Mathieu; Caylor, Kelly; Christner, Emanuel; Dyroff, Christoph; García, Omaira; González, Yenny; Griffis, Timothy; Kurita, Naoyuki; Liang, Jie; Liang, Mao-Chang; Lin, Guanghui; Noone, David; Gribanov, Konstantin; Munksgaard, Niels C; Schneider, Matthias; Ritter, François; Steen-Larsen, Hans Christian; Vallet-Coulomb, Christine; Wen, Xuefa; Wright, Jonathon S; Xiao, Wei; Yoshimura, Kei
发表日期：2019
文献求助 收藏

A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug-Drug Interaction Potential of the Cytotoxic Prodrug Evofosfamide

一种评估细胞毒性前药依沃福酰胺的细胞色素P450介导的药物相互作用潜力的新型PBPK模型方法

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12360
Lüpfert, Christian; Dyroff, Martin; von Richter, Oliver; Gallemann, Dieter; El Bawab, Samer; Dolgos, Hugues; Jung, Don; Hecht, Stefan; Johne, Andreas
细胞生物学
毒理研究
发表日期：2018
文献求助 收藏

Relationships between DNA adduct formation and carcinogenesis

DNA加合物形成与致癌作用的关系

期刊:Environmental Health Perspectives
影响因子:9.8
doi:10.1289/ehp.8562177
Swenberg, J A; Richardson, F C; Boucheron, J A; Dyroff, M C
肿瘤
肿瘤免疫
发表日期：1985
文献求助 收藏